title: Ubiquitin proteasome inhibition and cancer therapy.
authors.affiliation: Department of Surgery, University of Massachusetts Medical School, Worcester, USA.
authors.forename: Shimul A
authors.initials: SA
authors.lastname: Shah
authors.forename: Michael W
authors.initials: MW
authors.lastname: Potter
authors.forename: Mark P
authors.initials: MP
authors.lastname: Callery
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017209:Apoptosis / Q000502:physiology; D002453:Cell Cycle / Q000502:physiology; D002986:Clinical Trials as Topic; D003546:Cysteine Endopeptidases / Q000502:physiology; D019008:Drug Resistance, Neoplasm / Q000502:physiology; D006801:Humans; D009097:Multienzyme Complexes / Q000037:antagonists & inhibitors* / Q000502:physiology; D010447:Peptide Hydrolases / Q000502:physiology; D046988:Proteasome Endopeptidase Complex; D014158:Transcription, Genetic / Q000502:physiology; D025801:Ubiquitin / Q000037:antagonists & inhibitors* / Q000502:physiology
chemical_list: D000970:Antineoplastic Agents; D009097:Multienzyme Complexes; D025801:Ubiquitin; D010447:Peptide Hydrolases; D003546:Cysteine Endopeptidases; D046988:Proteasome Endopeptidase Complex; C061553:ATP dependent 26S protease